Navigation Links
Global Medical Oxygen Systems Industry
Date:9/5/2013

Table 60: Chinese Historic Review for Medical Oxygen Systems

by Product Segment - Oxygen Concentrators, Liquid Oxygen

Systems, Oxygen Cylinders & Regulators and Oxygen Conserving

Devices Markets Independently Analyzed with Annual Sales

Figures in US$ Thousand for Years 2004 through 2009

(includes corresponding Graph/Chart) III-84

 

Table 61: Chinese 15-Year Perspective for Medical Oxygen

Systems by Product Segment - Percentage Breakdown of Value

Sales for Oxygen Concentrators, Liquid Oxygen Systems,

Oxygen Cylinders & Regulators and Oxygen Conserving Devices

Markets for Years 2004, 2013 & 2018 (includes corresponding

Graph/Chart) III-85

 

5b. INDIA III-86

A.Market Analysis III-86

Current & Future Analysis III-86

Indian Medical Equipment Industry- A Primer III-86

A Peek into the Indian Medical Oxygen Business Environment III-86

Medical Oxygen Business Thrives through Recession III-87

Indian Oxygen Concentrator Market to Surge III-87

Imported Brands Dominate the Indian Oxygen Concentrator Market III-87

Product Launches III-88

B.Market Analytics III-89

Table 62: Indian Recent Past, Current & Future Analysis for

Medical Oxygen Systems by Product Segment - Oxygen

Concentrators, Liquid Oxygen Systems, Oxygen Cylinders &

Regulators and Oxygen Conserving Devices Markets

Independently Analyzed with Annual Sales Figures in US$

Thousand for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-89

 

Table 63: Indian Historic Review for Medical Oxygen Systems

by Product Segment - Oxygen Concentrators, Liquid Oxygen

Systems, Oxygen Cylinders & Regulators and Oxygen Conserving

Devices Markets Independently Analyzed with Annual Sales

Figures in US$ Thousan
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine technology :

1. Soligenix to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
2. Global Intravenous Solutions (Parenteral Nutrition) Industry
3. Questcor Pharmaceuticals to Participate in Morgan Stanley Global Healthcare Conference
4. Lexicon To Present At The Morgan Stanley Global Healthcare Conference
5. Global Cardiac Medical Devices 2009-2015 - Updated Report
6. Global Cardiac Rhythm Management (CRM) Devices - Market Growth Analysis, 2009-2015
7. BioReliance Opens New U.S. Clearance Services Laboratories; Completes Global Facility Upgrade Plan
8. Isis Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference
9. Immune Pharmaceuticals Inc. Presenting At The 15th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2013
10. One-Year Data From Global Atrial Fibrillation (AF) Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke
11. Auxilium Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
(Date:1/15/2014)... 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... application concerning composition of matter, biological targets, mechanism of ... death.  This patent application describes a ... molecules (VSRNAs) which interfere with the basic homeostatic cellular ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
(Date:4/16/2014)... HAMPTON, NJ (April 16, 2014): Celldex Therapeutics, Inc. ... Phase 1 study of CDX-1401 in solid tumors, including ... Translational Medicine (Vol 6 Issue 232). The data ... of clinical benefit in patients with very advanced cancers ...
(Date:4/15/2014)... States have nearly doubled since 1988, suggests new research from ... apparently to blame for the surge. The researchers also found ... groups equally, with alarming increases in diabetes in blacks, Hispanics ... the April 15, 2014 issue of the Annals of ...
(Date:4/15/2014)... San Diego School of Medicine have identified a mechanism that ... disease and why the virus is able to persist in ... which infects an estimated 200 million people worldwide, attacks the ... cell,s innate ability to fight infection. It does this by ...
(Date:4/14/2014)... and American Associations for Dental Research (IADR/AADR) have published ... Oral, and Craniofacial Manifestations." The complete review by researchers ... Michael Collins, Brian L. Foster, Rachel I. Gafni, Janice ... J. Timothy Wright is published in the OnlineFirst portion ...
(Date:4/14/2014)... West Orange, NJ. April 10, 2014. John DeLuca, PhD, ... from Biogen Idec to study how persons with multiple ... "The Use of Actual Reality to Measure Everyday Life ... conduct this research. Dr. DeLuca is senior VP of ...
Breaking Medicine News(10 mins):Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4Health News:Pre-diabetes and diabetes nearly double over the past 2 decades 2Health News:Breaking bad mitochondria 2Health News:Rare bone diseases and their dental, oral and craniofacial manifestations 2
... a troubled existence due to memory loss. The situation plummets ... patients live in The United Kingdom and most of them ... happen to such patients; lack of mental stimulation, social activity ... despair. ,The study, published in the journal Nature, ...
... do not pose a health hazard to workers in ... of 28,000 people, published ahead of print in// Occupational ... electromagnetic fields of 50 to 60 Hz has been ... breast cancers. ,The researchers used the health ...
... life in Rajasthan Monday as the mercury hovered between 40-45 ... ,The roads wore a deserted look with people preferring ... there would be no respite from the heat wave. ... of Rajasthan with the day temperatures four to six degrees ...
... for children, we have already been told. But now UK ... ,Professor Lawrie Challis, head of the government's committee on ... distance from the embedded antennas. ,Challis, a retired ... a desktop computer, the transmitter will be in the tower. ...
... Satraplatin, a chemotherapy drug has recently been tested ... Patients and found //to have significant improvement in ... University on Phase III trial on Satraplatin has ... for Improvement in Progression-Free Survival ...
... imagine when the cost of the error is three lives! ... in bad light following the irrevocable error committed by a ... explained how a weighing error committed by a worker during ... of three people in the Pacific Northwest, who consumed the ...
Cached Medicine News:Health News:Dementia – Worse With a Dull Life. Keep Busy, and Active to Improve Memory, Study Recommend 2Health News:Satraplatin Benefits Hormone Refractory Prostate Cancer Patients 2Health News:Satraplatin Benefits Hormone Refractory Prostate Cancer Patients 3Health News:Satraplatin Benefits Hormone Refractory Prostate Cancer Patients 4Health News:Satraplatin Benefits Hormone Refractory Prostate Cancer Patients 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: